(Q44347034)

English

Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies

scientific article published in January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

neuropathic pain

0 references

0 references

author name string

Ning Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shih-Yin Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lindsay A Hallett

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Luke Boulanger

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kimberly A Fraser

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chintan K Patel

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Yang Zhao

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

48-56

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Diabetic somatic neuropathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Diabetic peripheral neuropathy and quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Lost Productive Time and Costs Due to Diabetes and Diabetic Neuropathic Pain in the US Workforce

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

New perspectives on the management of diabetic peripheral neuropathic pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Safety profile of treatment in diabetic peripheral neuropathic pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Methods for improving regression analysis for skewed continuous or counted responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Treatment of symptomatic diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2010.00392.X

21 January 2018

Identifiers

10.1111/J.1533-2500.2010.00392.X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44347034&oldid=2109618738"